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Measles virus (MV)-induced immune suppression is an important reason for MV-associated mortality and morbidity.
Despite numerous studies, the mechanisms of immune suppression still remain poorly defined. In the present study we
analyzed the effect of MV components on the T-cell recognition of specific non-MV antigens. We demonstrated that even
inactivated MV could inhibit the presentation of unprocessed protein antigen to specific T cells, whereas MV did not affect
the responses of specific T cells to representative synthetic peptide epitopes derived from complex antigens. The inhibition
was induced by MV-infected cell membranes. The kinetics of the MV-dependent inhibition suggested an impaired antigen
processing in mononuclear cells as addition of MV-infected cell debris 4 h after the beginning of cell cultures no longer














Measles virus (MV) is a ubiquitous pathogen, which is
now rare in developed countries as a result of efficient
vaccination programs, but it is still an important cause of
death in several developing countries. MV-induced im-
mune suppression makes undernourished children es-
pecially susceptible to severe viral and/or bacterial com-
plications (Griffin and Bellini, 1996). An altered immune
function caused by MV infection was recognized in 1908
when von Pirquet reported that, during an acute MV
infection, children lost positive skin test for tuberculin
antigen (von Pirquet, 1908). On the other hand, suppres-
sion of the cell-mediated immunity may also give tempo-
rary relief in some autoimmune or allergic diseases
(Boner et al., 1985; Simpanen et al., 1977). MV infects
human peripheral blood mononuclear cells (PBMC) in
vivo (Sullivan et al., 1975b) and causes a lymphopenia,
mainly as a result of the reduced number of T cells,
whereas the ratio between CD4- and CD8-positive T
cells usually remains normal (Arneborn and Biberfeld,
1983; Ward et al., 1990). The number of B cells either may
remain normal or is slightly reduced. In addition to the
well-known suppression of T-cell reactivity, B cell and
monocyte functions are also disturbed by MV infection
(McChesney et al., 1989).
In vitro studies have shown that the proliferative re-
sponses of MV-infected T cells to mitogen or antigen are
strongly suppressed (Sullivan et al., 1975a), but the early
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422interleukin 2 production is not impaired (Borysiewicz et
al., 1985). MV also suppresses antibody production by B
cells (McChesney et al., 1986). Monocytes are infected
by MV and represent the major cell population infected in
nonstimulated PBMC cultures (Salonen et al., 1988), al-
though production of infective virus is not detected in
monocytes, even in the activated state (Vainionpa¨a¨ et al.,
1991). In resting lymphocytes MV infection is silent, but
stimulated T cells support productive virus replication,
which results in syncytia formation and cell lysis (Sulli-
van et al., 1975b). MV was found to inhibit the early phase
of PHA-induced lymphocyte stimulation when PBMC
were enriched for monocytes, but not in cell populations
where only few monocytes were present (Salonen et al.,
1989). MV infection of monocytes induces several
changes, which are reflected as abnormalities in cellular
functions. Interleukin 1b expression is enhanced, while
umor necrosis factor-a expression is reduced (Leopardi
t al., 1992). MV infection was also shown to downregu-
ate the production of interleukin 12, a key interleukin for
ell-mediated immunity (Karp, 1999). Because MV-in-
ected human mononuclear cells were not able to
resent exogenous antigen to specific T cells, the anti-
en-presenting function is also impaired (Leopardi et al.,
993).
The mechanisms of MV-induced immune suppression
till are not fully understood and are most likely multi-
actorial (Borrow and Oldstone, 1995). In the present
tudy we investigated antigen presentation of MV-
reated mononuclear cells to antigen-specific T cells. Our
esults show that impaired antigen processing in mono-
uclear cells prevents them from presenting whole, com-




































423MV COMPONENTS INHIBIT ANTIGEN PROCESSINGcells, but they still are able to efficiently present synthetic
peptides to epitope-specific T cells.
RESULTS
Inhibition of antigen presentation by MV-treated
PBMC
Initially the antigen-presenting function of MV-treated
PBMC was tested with RV- and coxsackie B4 virus
(CBV4)-specific T-cell lines. PBMC were incubated with
either infectious or heat-inactivated MV-infected Vero
cells at 5–10 multiplicities of infection. After 1-h incuba-
tion, PBMC were washed with RPMI and used as anti-
gen-presenting cells (APC). They were added together
with RV antigen or specific E1 peptides to restimulate
RV-specific T-cell lines. There was a clear inhibition of
T-cell proliferation with RV antigen when either infectious
or heat-inactivated MV-treated PBMC were used as APC
(Fig. 1). The mean degree of inhibition obtained from
eight independent experiments was 90% (range 71–98%).
Addition of human AB serum containing MV antibodies to
the cultures did not affect the results. Instead, when a
synthetic peptide known to contain T-cell epitope was
used as an antigen, APC treated with MV were as effi-
cient as control cells in presenting antigen to the specific
T-cell line (Fig. 1). In general, RV-specific T-cell prolifer-
ation to a 21 aa long E1 peptide p8 either remained the
same or even increased when MV-incubated PBMC
were used as APC instead of mock-incubated PBMC. MV
did not inhibit peptide presentation even at low concen-
tration (1.0 mg/ml) of peptide. Similar results were ob-
ained also with another RV-specific T-cell line and pep-
ide p77 from RV E1 protein as well as with CBV4-specific
FIG. 1. Responses of rubella virus (RV)-specific T-cell line to RV ant
protein E1. There is a clear inhibition of T-cell responses to RV antigen
MV) or inactivated MV-infected Vero cells (inactivated MV). Black colu
without antigen (medium) represent the spontaneous proliferation.-cell line and peptide p9 from CBV4 2C protein (data not
hown). well membrane associated MV components inhibit
ntigen presentation
Preparation of soluble and membrane fractions of MV-
nfected and control Vero cells is described under Ma-
erials and Methods. Identically prepared MV-infected
nd control Vero cell fractions were used to standardize
he amount of cellular proteins, although this resulted in
igher protein concentrations in MV lysates resulting
rom the virus-induced proteins. PBMC were incubated
ith different MV or control preparates for 1 h, washed
nce with RPMI, and used as APC in the proliferation
ests. The results showed (Fig. 2A) that cell debris from
he MV-infected Vero cells (MV-debris) almost totally in-
ibited proliferation, whereas the MV-supernatant 1, with
otal protein concentration more than two orders of mag-
itude higher than that of the MV-debris, had no effect.
he mean degree of inhibition by MV-debris in eight
eparate experiments was 87% (range 59–98%). The su-
ernatant 5 obtained from MV-debris washes did not
nhibit presentation. No inhibition was observed with any
f the uninfected Vero cell fractions (Fig. 2B). Further
xperiments demonstrated that, even at similar total pro-
ein concentrations, the inhibitory effect of inactivated
V-treated Vero cells was clear, although no inhibition
as seen by control Vero cell fraction. Trypan blue dye
xclusion did not show differences in the viability be-
ween the MV-debris- or mock-treated PBMC when the
ercentage of dead cells was calculated after various
ime periods (data not shown).
oluble MV hemagglutinin does not inhibit antigen
resentation
d to synthetic peptide (p8) containing amino acids 402–422 from RV
ntigen-presenting cells were incubated 1 h with infectious (infectious
ow the control responses without MV incubation and T-cell culturesigen an
when aMV hemagglutinin (H) is a transmembrane protein and
as thus a major candidate for being an inhibitory pro-
cubati
s).
424 MARTTILA ET AL.tein. To test its effect we incubated PBMC with purified H
and used them as APC, but did not see any inhibition of
RV antigen presentation to specific T cells (data not
shown). To elucidate whether the inhibition was based
on the combination of H with other cell membrane com-
ponents, we also incubated a control Vero cell prepara-
tion together with H, although this mixture did not have
any inhibitory effect. Preincubation of PBMC with H or
FIG. 2. Rubella virus (RV)-specific T-cell-line responses to RV antig
different measles virus (MV) preparates (MV-supernatant 5, MV-super
supernatant 5, control-supernatant 1, or control-debris) (B). After 1-h in
culture medium without antigen (for details, see Materials and MethodMV-supernatant 1 containing virus particles did not affect
the inhibition caused by MV-debris preparation.Kinetics of inhibition reveals that processing of
antigen is affected
To elucidate possible inhibitory mechanisms, PBMC
were incubated first with RV antigen and then, after
different time periods, either MV-debris fraction or only
medium was added, incubated for 1 h, washed, and used
as APC. Total inhibition was seen only when RV antigen
was added together with MV-debris or 1 h before that
to peptide p8. Antigen-presenting cells (APC) were incubated with
1, or MV-debris) (A) or with different control cell preparates (control-
on APC were washed and used to stimulate the T-cell line. Medium,en and
natant(Fig. 3). If RV antigen was added 2 h before adding the
MV-deb
425MV COMPONENTS INHIBIT ANTIGEN PROCESSINGMV-debris there was 50% inhibition, and if RV antigen
was added more than 4 h before MV-debris, no inhibition
was seen. The experiment indicates that MV inhibits a
time-consuming cellular process and its presence does
not affect the presentation of already processed antigen.
DISCUSSION
In this study we further characterized the effect of MV
on the antigen-presenting function. In our previous study
(Leopardi et al., 1993) we reported that MV-infected hu-
man mononuclear cells are unable to present non-MV
antigen to specific T cells. In the present study we show
that presentation of peptide epitopes by PBMC treated
with MV-debris was normal but MV-debris inhibits anti-
gen processing. Kinetic studies demonstrated that no
inhibitory effect was seen when MV-debris was added
4 h or later after the specific antigen, whereas up to 100%
inhibition was seen when MV was added earlier than 1 h
after the beginning of cell cultures.
Our experimental system used continuously growing
antigen-specific T-cell lines, which were stimulated by
autologous antigen-presenting cells (APC) loaded with
complex antigens or synthetic peptides. This approach
may reveal inhibitory mechanisms of MV, which are over-
laid by other mechanisms in experiments analyzing the
mitogen responsiveness in PBMC cultures. Previous
studies (Sanchez-Lanier et al., 1988; Schlender et al.,
1996) demonstrated that MV-infected PBMC can inhibit
proliferation of fresh autologous PBMC more vigorously
FIG. 3. Rubella virus (RV)-specific T-cell-line responses to RV antig
different time periods (0, 1, 2, 4, or 24 h) before adding MV cell debris (
T-cell line. Med, culture medium without antigen.than when MV is added to the cultures. They reported
that suppression did not depend on the interaction ofhemagglutinin (H) with MV receptor, the CD46 molecule.
Moreover, in our system the interaction with H and MV
receptor was not important. Recombinant H-incubated
PBMC could present RV antigen to the specific T cells.
Another possibility was that H, associated only with Vero
membrane, would be able to inhibit antigen presentation
by occupying MV receptor. To evaluate this hypothesis
we preincubated PBMC with purified H or with MV su-
pernatant containing soluble H protein. This preincuba-
tion did not affect the inhibition caused by MV-debris
preparate, indicating that the hypothesis was not correct.
Schlender and coworkers (1996) also demonstrated
that a combination of both MV glycoproteins was critical
for induction of the inhibition of mitogen-stimulated pro-
liferation. In their study productive infection of the re-
sponding cells was not necessary for the suppression,
although expression of both MV glycoproteins on the cell
surface was needed. In their system the inhibition oc-
curred via surface contact. The H and fusion protein (F)
are transmembrane proteins, which are expected to be
concentrated in the MV-debris fraction, and could thus
also be responsible for inhibition of the antigen-present-
ing function of mononuclear cells in our study. On the
other hand, the mitogen-induced activation does not in-
volve processing and presentation functions important in
antigen-induced activation and, hence, these studies
might not be relevant for the mechanisms of MV-induced
inhibition of antigen-dependent proliferation. In our ex-
perimental system the peptide-induced stimulation was
n antigen-presenting cells (APC) were incubated with RV antigen for
ris). After 1-h incubation APC were washed and used to stimulate theen whenot inhibited. MV-induced inhibition could not be blocked
by MV antibodies in our experiments, which also empha-
426 MARTTILA ET AL.sized the difference to the inhibition described by
Sanchez-Lanier and coworkers (1988). This probably in-
dicates that contact-dependent interaction between APC
and the MV-debris was not important, but rather that the
cell debris containing MV components is internalized by
monocytes via phagocytosis. Ability of the cell mem-
brane fraction containing MV protein to inhibit the anti-
gen presentation pathway might include several mech-
anisms. Interference with antigen uptake cannot explain
the phenomenon since strong inhibition was still de-
tected when MV-debris was added 2 h after the begin-
ning of the T-cell culture. This time is sufficient for the
absorption of exogenous antigens. The expression of
MHC class II molecules on cell membranes was also
sufficient because synthetic peptides added to the cul-
tures were efficiently presented, but we cannot yet an-
swer the question concerning which phases of the intra-
cellular antigen processing or MHC trafficking were af-
fected.
Escoffier and coworkers (1999) studied the replication
of recombinant MV defective in either C or V expression
in PBMC. They reported that infection of PBMC with the
recombinant MV defective in C protein impaired the
expression of H and F proteins on the PBMC surface, but
it was still able to inhibit PHA-stimulated PBMC prolifer-
ation, as could also the infection with recombinant MV
defective in V protein. This also demonstrated that con-
tact-dependent inhibition of PHA-stimulated PBMC pro-
liferation via cell-associated MV glycoproteins was not
the only inhibitory mechanism, nor were C and V proteins
necessary for the MV-induced inhibition. However, it
could be possible that H- and F-associated cell mem-
branes could induce the inhibition of antigen presenta-
tion. To evaluate this possibility it would be interesting to
use recombinant MV, defective in either C or F protein, to
infect Vero cells in our system.
Sun and coworkers (1998) demonstrated that T and B
cells infected with MV at low multiplicity of infection
secrete a soluble factor with antiproliferative activity, and
that the supernatant inhibited antigen-specific T-cell pro-
liferation. They also demonstrated that B cells treated
with this antiproliferative factor were unable to present
antigen to T cells (Fujinami et al., 1998). Their data
indicate the presence of yet another mechanism of inhi-
bition of antigen presentation to specific T cells. We used
inactivated, MV-infected Vero cells in contrast to infective
MV, and our “antiproliferative” material was associated
with the cell debris fraction only, and it was the antigen
processing by mononuclear cells that was impaired in
the case of incubation with inactivated MV. In our system
no effect of antiproliferative factors (e.g., cytokines di-
rectly affecting the T-cell proliferation) was seen, as
demonstrated by the normal proliferation response ob-
tained when peptide epitopes were used as antigens.In conclusion, our study showed that heat-inactivated
MV inhibited antigen presentation to antigen-specific Tcells. Further, antigen presentation was inhibited by a
cell-debris fraction containing MV-specific proteins but
not by MV supernatant fractions or by any of the control
fractions. In addition, we suggest that it was antigen
processing which was disturbed, because (1) T-cell pro-
liferation was normal with peptide antigen and (2) clear
inhibition was seen if the MV debris was added before
2 h from the beginning of T-cell culture. Whether the
described mechanism is involved in a natural MV infec-
tion and in the associated immune suppression remains
to be elucidated, but the results emphasize the multifac-
torial nature of MV-related immune suppression.
MATERIALS AND METHODS
Measles virus-infected and control Vero cells
Measles virus (Halonen strain; Vainionpa¨a¨ et al., 1978)
was grown in Vero cells using BME containing 0.2% BSA.
When the cytopathic effect was complete, the cells and
supernatant were collected, frozen in small volumes, and
used in inhibition experiments (MV-infected Vero cells).
The material was inactivated at 56°C for 2 h (inactivated
MV-infected Vero cells), and after heat inactivation no
infective MV particles were detected by plaque titration.
Control Vero cells were grown and prepared in the same
manner and used in inhibition experiment (control Vero
cells). The Vero cell line and the measles stock were
shown to be free of mycoplasma contamination.
Fractionated cell preparates (debris, supernatants)
To obtain separate cellular fractions, 9 ml MV-infected
and 9 ml uninfected (control) Vero cells were processed.
The preparates were centrifuged for 10 min at 2600 rpm
and supernatant 1 (MV- or control-supernatant 1) were
removed and stored. MV- and control-debris were sus-
pended in 2 ml PBS and sonicated with a stab sonicator
(Labsonic U Homo sonicator; Mediplus, Helsinki, Fin-
land) with five 10-s bursts with 5-s pauses in ice bath.
The samples were centrifuged at 2600 rpm for 10 min,
and MV- and control-supernatants 2 (2 ml) were col-
lected. The procedure was repeated for a third time and
after centrifugation, supernatants 2, 3, and 4 were com-
bined, resulting in 6 ml of combined supernatants 5 (5
supernatants 2 1 3 1 4). The washed MV- and control-
debris samples were resuspended in 1 ml PBS. Samples
were taken for quantitative protein analysis and SDS–
PAGE. The amount of protein was determined with the
Bradford method. The amount of total protein in MV
debris was four times higher than that of control debris.
SDS–PAGE was done with all samples on a 10% gel in
reducing conditions. Only MV-infected soluble and cell
membrane fractions gave a signal in SDS–PAGE immu-
nostaining with MV-specific polyclonal rabbit antibody to
MV. The stained bands of the MV-debris sample corre-





































427MV COMPONENTS INHIBIT ANTIGEN PROCESSING(not shown). Samples of the original cell suspension
supernatants (MV- or control-supernatants 1 and 5) and
the final sonicated debris (MV- or control-debris) were
reconstituted to the original 9-ml volume with PBS and
used in inhibition experiments.
MV-hemagglutinin
Measles virus hemagglutinin (H) was expressed in
Sf-9 insect cells using a recombinant baculovirus (Vi-
alard et al., 1990). Infected cells were washed, sus-
ended in a buffer containing 20 mM piperazine and 2%
odium deoxycholate, and homogenized by 20 strokes in
tight-fitting Dounce homogenizer. The resulting sus-
ension was clarified by ultracentrifugation, and the
emagglutinin was further purified by passing through a
entil-lectin column and finally dialyzed against PBS.
ubella and coxsackie B4 virus antigens and
ynthetic peptides
Rubella virus (RV) antigen and coxsackie B4 virus
CBV4) antigen were prepared as described earlier
Marttila et al., 1996). The synthetic peptides have been
escribed as T-cell epitopes in our earlier studies. The
V peptides were from amino acid (aa) positions 402–
22 (p8) (Ilonen et al., 1992) and aa 385–393 (p77) of the
1 protein (Marttila et al., 1996), and the coxsackie B4
peptide p9 from aa positions 81–100 of the 2C protein
(Marttila et al., submitted). The CBV4 lysate antigen and
all peptides were used at a final concentration of 10
mg/ml and RV lysate antigen 2.5 mg/ml.
ntigen-specific T-cell lines
Peripheral blood mononuclear cells (PBMC) were iso-
ated from heparinized venous blood by Ficoll–Paque
radient centrifugation. RV- and CBV4-specific T-cell
ines were established from PBMC by repeated stimula-
ion with RV or CBV4 antigen and interleukin 2 (IL-2, 20
/ml) in RPMI 1640 medium supplemented with 10%
uman AB serum, gentamycin sulfate (10 mg/ml), 1 M
epes buffer solution (20 ml/ml), and 3% glutamine (10
ml/ml). After 7 days, fresh medium supplemented with
IL-2 (20 U/ml) was added every second or third day. After
a total of 14 days from the beginning, the T cells were
restimulated with both specific antigen and irradiated (30
Gy) APC (2 3 106 PBMC/ml). T-cell lines were restimu-
ated at 7- to 12-day intervals, and IL-2 was added 2 days
fter antigen stimulation and at 2- to 3-day intervals
hereafter (Marttila et al., 1996).
ymphocyte proliferation assay
Triplicate or quadruplicate cultures of 1 3 104 antigen-
pecific T cells per well were incubated with 2 3 104PBMC and the different antigens in 200-ml volumes in
96-well round-bottom microtiter plates for 2 days. Triti-
Sated thymidine (2 mCi/ml) was added 18 h before har-
esting the cultures. Incorporated radioactivity was mea-
ured by 1450 Microbeta Plus liquid scintillation counter
Wallac Oy, Turku, Finland).
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